Cargando…
The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients
The dominant pathogenesis underlying the combined pulmonary fibrosis and emphysema (CPFE) remains unresolved. The receptor for advanced glycation end-products (RAGE) is highly expressed in lung tissues and interacts with distinct multiple ligands, implicating it in certain lung diseases. To elucidat...
Autores principales: | Kinjo, Takumi, Kitaguchi, Yoshiaki, Droma, Yunden, Yasuo, Masanori, Wada, Yosuke, Ueno, Fumika, Ota, Masao, Hanaoka, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393115/ https://www.ncbi.nlm.nih.gov/pubmed/32732977 http://dx.doi.org/10.1038/s41598-020-69184-8 |
Ejemplares similares
-
Comparison of gene expression profiling between lung fibrotic and emphysematous tissues sampled from patients with combined pulmonary fibrosis and emphysema
por: Hanaoka, Masayuki, et al.
Publicado: (2012) -
Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management
por: Hage, René, et al.
Publicado: (2021) -
The Impact of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Feng, Xiaoyi, et al.
Publicado: (2023) -
Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Papaioannou, Andriana I., et al.
Publicado: (2016) -
The blunted vascular endothelial growth factor-A (VEGF-A) response to high-altitude hypoxia and genetic variants in the promoter region of the VEGFA gene in Sherpa highlanders
por: Droma, Yunden, et al.
Publicado: (2022)